L-Tyrosine administration modulates the effect of transcranial direct current stimulation on working memory in healthy humans by Jongkees, B.J. et al.
1 
 
L-tyrosine administration modulates the effect of transcranial direct current stimulation on 
working memory in healthy humans 
 
Authors: Bryant J. Jongkees,
a
 Roberta Sellaro,
a
 Christian Beste,
b
 Michael A. Nitsche,
c,d,e
 
Simone Kühn,
f,g
 and Lorenza S. Colzato
a 
 
Affiliations: 
a
Institute of Psychological Research and Leiden Institute for Brain and Cognition, Leiden 
University, Wassenaarseweg 52, 2333 AK Leiden, The Netherlands 
b
Cognitive Neurophysiology, Department of Child and Adolescent Psychiatry, Faculty of 
Medicine of TU Dresden, Fetscherstrasse 74, 01307 Dresden, Germany 
c
Department of Clinical Neurophysiology, Georg-August University Göttingen, 
Wilhelmsplatz 1, 37073 Göttingen, Germany 
d
Leibniz Research Centre for Working Environment and Human Factors, Ardeystraße 67, 
44139 Dortmund, Germany 
e
Department of Neurology, University Medical Hospital Bergmannsheil, Bürkle de la Camp-
Platz 1, 44789 Bochum, Germany 
f
Center for Lifespan Psychology, Max Planck Institute for Human Development, Lentzeallee 
94, 14195 Berlin, Germany 
g
Department of Psychiatry and Psychotherapy, University Clinic Hamburg-Eppendorf, 
Martinistrasse 52, Hamburg, Germany 
  
Corresponding author: Bryant Jongkees, Department of Cognitive Psychology, 
Wassenaarseweg 52, 2333 AK Leiden, The Netherlands. E-mail: 
b.j.jongkees@fsw.leidenuniv.nl 
 
Word count Abstract: 259 
Word count Main Body: 7345 
 
Conflict of Interest: M. A. Nitsche is a member of the Advisory Board of Neuroelectrics. 
The other authors declare no conflicts of interest. 
  
 
2 
 
Abstract 
Background: Transcranial direct current stimulation (tDCS) is an increasingly popular method 
of modulating cognitive functions in humans. However, some doubt its efficacy as findings 
are inconsistent or remain unreplicated. It is speculated dopamine (DA) might play an 
important role in this inconsistency, by determining the direction and strength of the 
cognitive-behavioural effects of tDCS. However, so far evidence for this hypothesis has been 
correlational in nature, precluding definitive conclusions.  
 
Objective: The present proof-of-principle study aimed at investigating a potentially causal 
role for DA in the effect of tDCS on cognition in healthy humans.  
 
Methods: In experiment 1 we aimed to replicate previous findings showing administration of 
DA’s precursor L-Tyrosine (Tyr), presumably by inducing a modest increase in DA level, can 
enhance working memory performance as assessed with a verbal N-back task. In experiment 2 
we investigated the effect of Tyr administration on bilateral tDCS over dorsolateral prefrontal 
cortex (DLPFC) and working memory. 
 
Results: Experiment 1 showed Tyr administration enhances performance in a verbal N-back 
task. Experiment 2 showed Tyr modulates the effect of bilateral tDCS over DLPFC on 
working memory. Specifically, tDCS had opposite effects on performance depending on 
current direction through the brain and Tyr administration.  
 
Conclusions: The present study provides two major findings. First, we replicate Tyr’s 
beneficial effect on verbal working memory. Second, our results indicate a causal role for DA 
in the effect of tDCS on cognition. For this reason, we encourage future studies to consider 
the modulating effect of DA, as a step towards more consistent and replicable results 
regarding the efficacy of tDCS.  
  
Keywords: Transcranial direct current stimulation; tyrosine; dopamine; working memory  
3 
 
1. Introduction 
Transcranial direct current stimulation (tDCS) is an increasingly popular, non-invasive 
method for modulating cognitive functions in healthy individuals and psychiatric patients 
(Plewnia, Schroeder, & Wolkenstein, 2015). tDCS induces a polarity-dependent shift in the 
resting membrane potential of cortical neurons, altering their likelihood of firing (Nitsche & 
Paulus, 2000) and longer stimulation results in neuroplastic after-effects (Nitsche & Paulus, 
2001; Nitsche, Nitsche, et al., 2003). However, some still doubt the efficacy of tDCS in 
enhancing cognitive-behavioral performance, as many findings have so far not been subject of 
replication, and the effects of tDCS have some variability (Horvath, Forte, & Carter, 2015a, 
2015b), but see (Antal, Keeser, Priori, Padberg, & Nitsche, 2015). Although much variation in 
results could be due to methodological differences between studies (e.g. stimulation duration, 
electrode placement) (Plewnia et al., 2015), another source of variance might stem from 
dopamine (DA) function (L. M. Li, Uehara, & Hanakawa, 2015). This idea is corroborated by 
the finding that tDCS differentially affects individuals carrying certain DA-related genetic 
polymorphisms (Nieratschker, Kiefer, Giel, Krüger, & Plewnia, 2015; Plewnia et al., 2013). 
However, given the inherently correlational nature of genetic studies, it remains unconfirmed 
whether DA plays a causal role in modulating the cognitive-behavioral effects of tDCS. 
Previous studies investigating the effect of DA manipulations on tDCS focused only on the 
electrophysiological effects of tDCS in the motor cortex (Fresnoza, Paulus, Nitsche, & Kuo, 
2014; Fresnoza, Stiksrud, et al., 2014; M.-F. Kuo, Paulus, & Nitsche, 2008; Monte-Silva et 
al., 2009; Monte-Silva, Liebetanz, Grundey, Paulus, & Nitsche, 2010; Nitsche et al., 2006; 
Nitsche, Kuo, Grosch, et al., 2009). In contrast, no studies have investigated the effect of DA 
manipulations on the cognitive-behavioral effects of tDCS. Hence, it remains unclear whether 
DA can indeed contribute to variability of results obtained with prefrontal tDCS. 
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 Although available evidence suggests DA modulates the physiological and behavioral 
effects of tDCS, it remains speculative why this is the case. One reason DA might interact 
with the acute effects of online tDCS (i.e. stimulation coinciding with task performance) 
might be because both tDCS and DA target resting membrane potentials. Anodal (excitatory) 
and cathodal (inhibitory) stimulation increase and decrease resting membrane potentials 
respectively (Nitsche & Paulus, 2000), whereas DA enhances and reduces firing of neurons 
with high and low membrane potentials, respectively (Frank, 2005; Hernández-López, 
Bargas, Surmeier, Reyes, & Galarraga, 1997). As such, DA is known to modulate task-
induced cortical activity (Egan et al., 2001; Mattay et al., 2003) and, in turn, task-induced 
activity has been identified as a possible determinant of tDCS effects (Antal, Terney, Poreisz, 
& Paulus, 2007; Bortoletto, Pellicciari, Rodella, & Miniussi, 2015). This suggests changes in 
background and task-dependent neural firing might mediate an effect of DA on online tDCS. 
On the other hand, DA might modulate the after-effects of tDCS on cortical excitability by 
also acting on N-methyl-d-aspartate (NMDA) receptors. These receptors mediate 
neuroplasticity via long-term potentiation (LTP) and depression (LTD) (Lüscher & Malenka, 
2012) and are thought to underlie the neuroplastic after-effects of tDCS (Liebetanz, Nitsche, 
Tergau, & Paulus, 2002; Nitsche et al., 2004; Nitsche, Fricke, et al., 2003). Previous animal 
studies show DA can facilitate the induction and consolidation of LTP and LTD, but results 
have varied for different receptor subtypes (Gurden, Takita, & Jay, 2000; Huang, Simpson, 
Kellendonk, & Kandel, 2004; Spencer & Murphy, 2000). In line with these findings, Nitsche 
et al. (2006) reported that pharmacologically blocking D2 receptors nearly abolished the after-
effects of tDCS on cortical excitability, whereas activation of D2, and to a lesser-extent D1, 
prolonged these effects. Additionally, Kuo et al. (2008) demonstrated L-dopa administration 
turned an excitability enhancement due to anodal tDCS into a diminishment, whereas the 
inhibitory after-effects of cathodal tDCS were prolonged. Taken together these findings 
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establish a role for DA in the acute and long-term physiological effects of tDCS, but so far 
studies investigating if and how this translates to cognition and behavior remain scarce.  
 Hence, in the present study we set out to clarify the (potentially causal) relation 
between DA and the cognitive-behavioral effects of prefrontal tDCS. To this end we 
investigated whether a modest increase in DA in healthy individuals modulates the effect of 
tDCS on (verbal) working memory (WM), a core cognitive function (Miyake et al., 2000) 
often investigated in relation to tDCS. Slight increases in DA level can be achieved by 
administration of DA’s biochemical precursor l-tyrosine (Tyr), which can enhance a variety of 
DA-related cognitive functions in humans (Jongkees, Hommel, Kühn, & Colzato, 2015). Thus 
we reasoned if a simple DA manipulation such as Tyr administration would modulate the 
effect of tDCS on WM, then this would provide first tentative support for a causal role of DA 
in the cognitive-behavioral effects of tDCS. Following earlier studies on a DA manipulation 
on tDCS (M.-F. Kuo et al., 2008; Nitsche et al., 2006), we have restricted our investigation to 
the after-effects of tDCS.  
We applied bilateral tDCS over the dorsolateral prefrontal cortex (DLPFC), a region 
strongly implicated in WM (Curtis & D’Esposito, 2003) and often targeted with tDCS. Many 
studies show WM improvements with tDCS by applying anodal stimulation over the left 
DLPFC, with the cathodal return electrode being placed over the contralateral orbital region 
(Fregni et al., 2005; Hoy et al., 2013; Jeon & Han, 2012; Mulquiney, Hoy, Daskalakis, & 
Fitzgerald, 2011; Ohn et al., 2008; Oliveira et al., 2013; Teo, Hoy, Daskalakis, & Fitzgerald, 
2011) or symmetrically over the right DLPFC (Oliveira et al., 2013). Stimulation with the 
opposite montage, i.e. with the cathode over left DLPFC, is less-investigated but may impair 
performance (Marshall, Mölle, Siebner, & Born, 2005), although this result was obtained with 
intermittent (15s on/off) rather than the more common continuous stimulation. Given this 
pattern of results we hypothesized that, after placebo intake, individuals receiving anodal over 
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left, cathodal over right (AL-CR) stimulation would show higher WM performance than those 
receiving cathodal over left, anodal over right (CL-AR) stimulation. Given the hypothesized 
causal role of DA in the effects of tDCS, we expected a modulation of this pattern of results 
after administration of Tyr. 
 In short, we aimed to provide first tentative evidence supporting a causal role for DA 
in the cognitive-behavioral effects of tDCS by investigating whether administration of Tyr 
modulates the effects of two tDCS montages on WM as assessed in a verbal N-back task. 
 
2. Material and methods 
2.1 Overview. We performed two separate experiments. To support the notion Tyr modestly 
enhances WM performance, in experiment 1 we aimed to replicate previous findings showing 
beneficial effects of Tyr administration on WM performance (Colzato, Jongkees, Sellaro, & 
Hommel, 2013) in a double-blind between-subjects design. Participants consumed either 2.0 g 
of Tyr or placebo and 1 h later, when plasma Tyr levels start to peak (Glaeser, Melamed, 
Growdon, & Wurtman, 1979), their WM performance was tested on a verbal N-back task. In 
experiment 2 we assessed the interaction between two tDCS montages (AL-CR vs. CL-AR) 
and administration of Tyr or placebo in a single-blind, between-subjects design. As in 
experiment 1, participants consumed either 2.0 g of Tyr or placebo. 1 h later they received 15 
min of either AL-CR or CL-AR stimulation over bilateral DLPFC and subsequently their WM 
performance was tested using the same N-back task as in experiment 1. The studies 
conformed to the ethical standards of the declaration of Helsinki, the protocols were approved 
by the local ethical committee (Leiden University, Institute for Psychological Research), and 
volunteers signed an informed consent form before participation. 
 
2.2 Experiment 1 
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2.2.1 Participants. 36 students were recruited from Leiden University and randomly assigned 
to one of two groups: placebo or Tyr. Each group consisted of 18 participants. The two groups 
were comparable with respect to age, F(1, 34) = 3.42, p = .073, weight, F(1, 34) = .44, p = 
.513, body-mass index (BMI), F(1, 34) = .287, p = .595, and identical with respect to gender 
distribution. Group demographics are shown in Table 1. Participants were screened 
individually using the Mini International Neuropsychiatric Interview (M.I.N.I.) (Sheehan et 
al., 1998). The M.I.N.I. is a well-established brief diagnostic tool in clinical, drug, and stress 
research that screens for several psychiatric disorders and drug use (Colzato & Hommel, 
2008; Colzato, Kool, & Hommel, 2008; Sheehan et al., 1998). As such, all participants were 
screened for physical and mental health problems. Individuals with recent or regular drug use 
were excluded from participation. One exception to this was hormonal contraceptive 
medication, which all female participants had to be using regularly to limit fluctuations in 
hormone levels associated with the menstruation cycle as these can influence DA function and 
thereby confound results related to DA (Colzato & Hommel, 2014; Czoty et al., 2009; Jacobs 
& Esposito, 2011). The specific type or brand of contraception was not recorded. None of the 
participants reported any health problems. 
 
INSERT TABLE 1 
 
2.2.2 Task design. The N-back task is conceptualized to assess WM performance (Kane, 
Conway, Miura, & Colflesh, 2007) and, indeed, is often used in tDCS studies investigating 
WM (Au et al., 2016; Fregni et al., 2005; Hoy et al., 2013; Mylius et al., 2012; Ohn et al., 
2008; Oliveira et al., 2013; Teo et al., 2011; Zaehle, Sandmann, Thorne, Jäncke, & Herrmann, 
2011). The present study used a letter-based, i.e. verbal version of the task (Colzato et al., 
2013). A 1-back condition might be too easy to find positive effects of Tyr (Colzato et al., 
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2013) and previous studies on tDCS and the N-back task have primarily used 2-back and 3-
back conditions. Hence to keep the experiments comparable we included both 2-back and 3-
back conditions in experiment 1 and 2. The 2-back condition was always presented first.  
Stimuli were presented in the middle of a computer screen with a refresh rate of 60 Hz 
and a 800 x 600 resolution using E-Prime 2.0 software. Participants were comfortably seated 
approximately 50 cm from the screen while wearing headphones. Responses were given using 
the ‘z’ and ‘m’ buttons of a QWERTY keyboard. Mapping of response buttons to target (i.e. 
repetition) and non-target (i.e. non-repetition) was counterbalanced across participants in each 
group. After an incorrect or belated response (latency longer than 1000 ms) a brief tone was 
presented to signal a mistake. Both the 2-back and the 3-back conditions consisted of two 
blocks of 51 + n trials. For example, a 2-back block consisted of 53 trials. Regardless of the 
current load condition, each block comprised 21 targets and 30 non-targets. All participants 
performed the 2-back condition first and then the 3-back condition, and each n-back condition 
was preceded by 17+n practice trials (7 targets and 10 targets). 
 Aside from parameters such as hit rates and correct rejections, we were mainly 
interested in target sensitivity, indexed by d’ prime derived from signal detection theory 
(Swets, Tanner, & Birdsall, 1961). This informative measure combines hit and false alarm 
rates and thus provides an index of the ability to discriminate targets from non-targets, with 
higher scores signaling selective, correct reporting of targets, and thus better WM 
performance. Hence we expected higher d’ prime scores after Tyr administration. d’ prime 
was calculated, and perfect scores were corrected for, as described earlier (Colzato et al., 
2013). One participant had a perfect hit rate and another had zero false alarms. 
 
2.2.3 Tyrosine administration. To induce a moderate increase in DA we administered DA’s 
precursor Tyr. Upon consumption Tyr is converted into L-dopa, which is subsequently 
9 
 
converted into DA. Consistent with the hypothesis that Tyr administration increases DA, 
animal studies showed increased levels of prefrontal DA and homovanillic acid (HVA), the 
main metabolite of DA, after Tyr intake (Tam, Elsworth, Bradberry, & Roth, 1990; Tam & 
Roth, 1997). Although in vivo, direct assessment of DA in humans is difficult, Tyr 
administration has been shown to significantly elevate levels of HVA in the spinal fluid of 
Parkinson’s patients, suggesting an increase in DA (Growdon, Melamed, Logue, Hefti, & 
Wurtman, 1982). 
Previous studies showed doses of Tyr as low as 2.0 g have positive effects on WM 
performance as measured using the N-back task (Colzato et al., 2013) and a variety of other 
cognitive functions (for a review, see Jongkees et al., 2015), suggesting this dose is sufficient 
for inducing a modest but functionally relevant increase in DA level. With the aim of 
replicating these findings, we administered 2.0 g of Tyr in the present study. The neutral 
substance microcrystalline cellulose was used as placebo (Thomas, Lockwood, Singh, & 
Deuster, 1999). Tyr or placebo was dissolved in 400 mL of orange juice.  
As we did not adjust the dosage of Tyr to the individual participant’s weight and BMI, 
this might have led to variation in response to the administration due to different substance 
concentration levels. To control for this source of variance we included BMI as covariate in 
our analyses. 
 
2.2.4 Procedure. Participants came to the lab in the morning, having fasted since 10 o’clock 
in the evening prior to participation (Cuche et al., 1985; Glaeser et al., 1979). Informed 
consent was obtained and BMI was measured. Subsequently participants consumed 2.0 g of 
Tyr or placebo dissolved in 400 mL orange juice. Afterwards they were offered apples and 
oranges, which contain negligible amounts of Tyr, to prevent strong hunger. 1 h after 
finishing the juice participants started the N-back task, which took approximately 20 min. 
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Lastly, participants were debriefed and compensated for their participation with course credit 
or €10.  
 
2.2.5 Statistical analysis. To assess the effect of Tyr intake on WM performance we 
conducted repeated measures ANCOVA with administration (placebo vs. Tyr) as between-
subjects factor, WM load (2-back vs. 3-back condition) as within-subjects factor, BMI as 
covariate, and d’ prime as the dependent measure. Similar analyses were performed using hit, 
false alarm, correct rejection, and miss rates, and reaction times (RT) as dependent measures. 
 
2.3 Experiment 2 
2.3.1 Participants. 72 right-handed students were recruited from Leiden University. 
Participants were randomly assigned to one of four groups: AL-CR stimulation plus placebo, 
AL-CR stimulation plus Tyr, CL-AR stimulation plus placebo, or CL-AR stimulation plus 
Tyr. Each group consisted of 18 participants, which is comparable with—if not more than—
previous tDCS studies on WM (Fregni et al., 2005; Hoy et al., 2013; Jeon & Han, 2012; 
Marshall et al., 2005; Mulquiney et al., 2011; Mylius et al., 2012; Ohn et al., 2008; Teo et al., 
2011) and previous studies investigating the effect of a DA manipulation on the 
electrophysiological effects of tDCS (Fresnoza, Paulus, et al., 2014; Fresnoza, Stiksrud, et al., 
2014; M.-F. Kuo et al., 2008; Monte-Silva et al., 2009, 2010; Nitsche et al., 2006; Nitsche, 
Kuo, Grosch, et al., 2009). The four groups were comparable with respect to age, F(3, 68) = 
1.59, p = .201, weight, F(3, 68) = 1.89, p = .140, BMI, F(3, 68) = 1.00, p = .400, and gender 
distribution, X
2
(3) = .32, p = .956. Group demographics are shown in Table 1. Participants 
were again selected using the M.I.N.I (Sheehan et al., 1998) and underwent the same health 
screening as described in experiment 1. Additionally, individuals with implants such as 
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pacemakers, any kind of metal in their body, or skin conditions were excluded for safety 
reasons concerning the tDCS. None of the participants reported any health problems.  
 
2.3.2 Task design. The same letter-based, verbal N-back task used in experiment 1 was used to 
assess WM performance. In line with our hypotheses in the Introduction, after placebo intake, 
we expected higher d’ prime scores when stimulating with a typically performance-enhancing 
AL-CR, as compared to a typically impairing CL-AR montage. Given the hypothesized role 
of DA in the effects of tDCS, we expected these results to be modulated by Tyr. 
One participant in the CL-AR plus Tyr group achieved a perfect hit rate in the 2-back 
condition and hence this score was corrected (Colzato et al., 2013). No participant achieved 
zero false alarm rates. 
 
2.3.3 Transcranial direct current stimulation. Two electrodes of 35 cm
2
 (5 cm x 7 cm) were 
placed over DLPFC in a bilateral bipolar-balanced montage (Nasseri, Nitsche, & Ekhtiari, 
2015), i.e. in symmetrical positions. Although many tDCS studies on WM have previously 
placed the return electrode over the contralateral supraorbital region, we opted for 
symmetrical positioning of electrodes to avoid uncertainty over where in the supraorbital 
region the electrode was placed. Additionally, and more importantly, this positioning served 
to maximize the likelihood current direction through the brain would be comparable across 
participants, thus reducing potential variability in response to the stimulation. For each 
individual participant the DLPFC was located using the international 10/20 system for placing 
electrodes on the scalp (Jasper, 1958). Accordingly, for the AL-CR montage the anode and 
cathode were placed over F3 and F4, respectively. For the CL-AR montage this placement 
was reversed.  
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Stimulation consisted of a current of 1000 µA delivered by a DC Brain Stimulator Plus 
(NeuroConn, Ilmenau, Germany), a device complying with the Medical Device Directive of 
the European Union (CE-certified). The current was built up during a fade-in of 10 s, after 
which stimulation lasted for precisely 15 min and then ended with a 10 s fade-out. Impedance 
was below 15 kΩ throughout the stimulation. The after-effects of 15 min of tDCS typically 
last 1 h (Nitsche et al., 2008). We assessed WM performance off-line, that is after stimulation 
had finished. This mirrors the design of previous studies investigating the effect of DA 
manipulations on tDCS-induced cortical excitability. For example, Nitsche et al (2006) and 
Kuo et al. (2008) administered DA agents to participants, then stimulated the motor cortex 
and afterwards measured cortical excitability. Additionally, it is important to consider the 
effects of online tDCS may be particularly state-dependent, i.e. there may be variation in 
response due to differences in task-induced activity or baseline performance across 
participants (Antal et al., 2007; Bortoletto et al., 2015). To avoid minimize such a confound in 
our results we opted for offline assessment of WM performance.  
 The experience of side-effects due to tDCS was assessed through self-report ratings 
for the following symptoms: head ache, neck pain, nausea, muscle contractions in the face or 
neck, stinging sensation under the electrodes, burning sensation under the electrodes, and a 
nonspecific, uncomfortable feeling. Consistent with previous studies the most prominent side-
effects were stinging and burning sensations under the electrodes (Bikson, Datta, & Elwassif, 
2009), although none of the participants voiced major complaints.  
 
2.3.4 Tyrosine administration. As in experiment 1, we administered 2.0 g of Tyr or a placebo 
dissolved in 400 mL orange juice.  
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2.3.5 Procedure. The experimental procedure was similar to experiment 1. Participants came 
to the lab in the morning, having fasted since 10 o’clock in the evening prior to participation 
(Cuche et al., 1985; Glaeser et al., 1979). Informed consent was obtained and BMI was 
measured. Subsequently participants consumed 2.0 g of Tyr or placebo dissolved in 400 mL 
orange juice. Afterwards they were offered apples and oranges to prevent strong hunger. 45 
min after finishing the juice the tDCS montage was applied. After mounting the electrodes on 
the head, which took approximately 10 to 15 min, at precisely 1 h after Tyr or placebo 
administration the stimulation was started. Once the 15 min stimulation had finished the 
montage was removed. The participants then started the N-back task, which took 
approximately 20 min. Afterwards, participants’ experience of any side-effects due to tDCS 
was rated. Lastly, participants were debriefed and compensated for their participation with 
course credit or €15.  
 
2.3.6 Statistical analysis. To assess the effect of tDCS combined with Tyr we performed 
repeated measures ANCOVA with montage (AL-CR vs. CL-AR) and administration (placebo 
vs. Tyr), as between-subjects factors, WM load (2-back vs. 3-back condition) as within-
subjects factor, d’ prime as the dependent measure, and BMI as covariate. Similar analyses 
were performed for hit, false alarm, correct rejection, and miss rates, and RT as dependent 
measures. 
 A significant interaction between montage and administration was further investigated 
with additional ANCOVAs to disentangle this effect on WM performance according to our 
main hypothesis. Control comparisons between experiment 1 and 2 were performed to further 
clarify the effect of combined tDCS and Tyr relative to administration of only Tyr. 
 
3. Results 
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3.1 Experiment 1 
3.1.1 Target sensitivity. To replicate the positive effect of Tyr intake on WM performance, 
participants completed a letter-based N-back task after they consumed either placebo or Tyr. 
For d’ prime scores, there was a significant effect of WM load, F(1, 33) = 10.45, p = .003, 
partial η2 = .241. This indicates significantly higher d’ prime scores in the 2-back condition 
(M = 2.74) than in the 3-back condition (M = 1.99). More importantly, there was a main effect 
of administration, F(1, 33) = 6.94, p = .013, partial η2 = .174. Target sensitivity was 
significantly higher after intake of Tyr (M = 2.69) than after placebo (M = 2.05). There was no 
significant interaction between WM load and administration, F(1, 33) = 1.01, p = .321, 
suggesting the effect of Tyr was comparable in the 2-back and 3-back conditions. 
 
3.1.2 Other N-back parameters. Results for hits, misses, correct rejections, false alarms, and 
RT were similar to d’ prime. Means are listed in Table 2. 
 For hits and misses there was again a main effect of administration, F(1, 33) = 5.30, p 
= .028, partial η2 = .138. This suggests significantly higher hit rates and less misses after 
intake of Tyr (M = .86 and .14, respectively) than after placebo (M = .78 and .22, 
respectively). Similarly, for correct rejections and false alarms there was also a main effect of 
administration, F(1, 33) = 6.81, p = .014, partial η2 = .171. This indicates significantly higher 
correct rejection and lower false alarm rates after Tyr intake (M = .92 and .08, respectively) 
than after placebo (M = .84 and .16, respectively). 
 For RT on target trials, there was no significant effect of administration, F(1, 33) = 
3.00, p = .093, partial η2 = .083. However, for RT on non-target trials there was a significant 
effect of administration, F(1, 33) = 4.97, p = .033, partial η2 = .131, indicating faster 
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responses on non-target trials after Tyr intake (M = 559) than after intake of placebo (M = 
609).  
 
INSERT TABLE 2 
 
3.1.3 BMI. For the sake of clarity we discuss the BMI results in this separate section. There 
were no significant main effects of BMI, all p > .05. Interestingly, there was a significant 
interaction between BMI and load when analyzing the d’ prime scores, p = .015. However 
separate regression analyses for the two load conditions (2-back and 3-back) with BMI as 
predictor and d’ prime as dependent measure revealed no significant effect of BMI on d’ 
prime in either condition, ps > .05. Plotting the data revealed the interaction was likely driven 
by a tendency for d’ prime scores to be lower in the 2-back condition with increasing BMI, 
whereas this tendency was not observed in the 3-back condition. Lastly, in separate analyses 
we confirmed the effect of BMI did not differ in our two groups as indicated by a 
nonsignificant BMI and group interaction, ps > .05. 
 
3.2 Experiment 2 
3.2.1 Target sensitivity. To investigate whether Tyr modulates the effect of tDCS on WM, 
participants completed a letter-based N-back task after being administered either placebo or 
Tyr and having been stimulated for 15 min with an AL-CR or CL-AR montage. For d’ prime, 
there was a significant effect of WM load, F(1, 67) = 5.23, p = .025, partial η2 = .072. 
Specifically, scores in the 2-back condition (M = 2.35) were significantly higher than in the 3-
back condition (M = 1.67). There were no significant interactions between WM load and 
montage, F(1, 67) = .06, p = .811, between WM load and Tyr administration, F(1, 67) = .42, p 
= .520, or between WM load and both montage and Tyr administration, F(1, 67) = .01, p = 
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.921, suggesting the difference in difficulty between the 2-back and 3-back conditions was 
experienced similarly across the four groups.  
More importantly, although we did not find a main effect of montage F(1, 67) = 2.79, 
p = .099, or Tyr administration, F(1, 67) = .09, p = .771, we did find a significant interaction 
between montage and Tyr administration, F(1, 67) = 4.81, p = .032, partial η2 = .067. This 
indicates target sensitivity was modulated by the combination of tDCS and Tyr. The 
interaction is illustrated in Figure 1. To disentangle this interaction, we ran separate 
ANCOVAs for the placebo and Tyr groups. After placebo intake there was only a small, non-
significant difference between the AL-CR and CL-AR montages in terms of d’ prime (M = 
2.06 vs. 1.99), F(1, 33) = .10, p = .749. However, after Tyr intake there was a larger, 
significant difference between the AL-CR and CL-AR montages in the opposite direction of 
typical results on tDCS and WM, F(1, 33) = 6.50, p = .016, partial η2 = .165. That is, d’ prime 
scores were higher after CL-AR stimulation was combined with Tyr (M = 2.23) than when the 
typically WM-enhancing AL-CR stimulation was combined with Tyr (M = 1.75), see Figure 
1. This finding suggests inducing a moderately higher DA level in participants modulates the 
effect of tDCS on WM and, strikingly, leads a typically-enhancing stimulation montage to 
impair performance. This finding provides first evidence in favor of a causal role for DA in 
the cognitive-behavioral effects of prefrontal tDCS. 
 
INSERT FIGURE 1 
 
3.2.2 Other N-back parameters. Results for hits and misses showed similar patterns to d’ 
prime. Means are listed in Table 3.  
For hits and misses there was no main effect of montage, F(1, 67) = 1.82, p = .182, nor 
Tyr administration, F(1, 67) > .001, p = .987, but again there was a significant interaction 
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between montage and Tyr administration, F(1, 67) = 5.46, p = .022, partial η2 = .075. 
Additional ANCOVAs revealed a significant difference between the montages after Tyr 
intake, F(1, 67) = 7.31, p = .011, partial η2 = .181. As with d’ prime scores, the CL-AR group 
showed higher performance (i.e., more hits and less misses) than the AL-CR group when 
combined with Tyr, whereas no difference was observed when combined with placebo, F(1, 
33) = .40, p = .529. There were no significant 2 or 3-way interactions between WM load, 
montage and Tyr administration, all ps > .398. 
For correct rejections and false alarms there were no main effects of montage, F(1, 67) 
= 2.25, p = .138, or Tyr administration, F(1, 67) = .41, p = .523, nor an interaction between 
montage and Tyr administration, F(1, 67) = 1.73, p = .193. The only significant interaction 
involved WM load and montage, F(1, 67) = 4.14, p = .046, partial η2 = .058, indicating 
responses to non-targets were modulated by tDCS montage and this modulation differed 
between the 2-back and 3-back conditions. A post hoc pairwise comparison of the two 
montages for each level of WM load revealed no significant difference between the two 
montages in the 2-back condition, p = .909, whereas the two montages did differ significantly 
in the 3-back condition, p = .034, partial η2 = .065. Specifically, participants who were 
stimulated with an AL-CR montage showed overall less correct rejections and, 
correspondingly, more false alarms (M = .81 and .19, respectively) as compared to those 
stimulated with a CL-AR montage (M = .85 and .15, respectively), but only in the 3-back 
condition. It should be noted this interaction was independent of whether participants were 
given placebo or Tyr.  
For RT on target and non-target trials there were no significant effects of montage or 
Tyr administration, nor any 2 or 3-way interactions between WM load, montage, and Tyr 
administration, all ps > .327. 
 
18 
 
INSERT TABLE 3 
 
3.2.3 Control comparisons. We performed control comparisons to gain insight in how 
stimulation (AL-CR and CL-AR) combined with placebo or Tyr affected performance relative 
to administering placebo or Tyr without tDCS. To this end we performed two additional 
ANCOVA’s in which we separately compared performance of the groups receiving placebo 
or Tyr in experiment 2 to the group that received placebo or Tyr in experiment 1, respectively. 
Since hits and misses followed the same pattern of results as d’ prime, we only performed 
comparisons for the latter. 
 For the placebo groups, a repeated measures ANCOVA was performed with group 
(placebo-only vs. AL-CR stimulation plus placebo vs. CL-AR stimulation plus placebo) as 
between-subjects factor, WM load (2-back and 3-back condition) as within-subjects factor, 
BMI as covariate, and d’ prime as dependent measure. There was no main effect of group, 
F(1, 50) = .04, p = .960, suggesting placebo plus tDCS did not affect performance as 
compared to administration of only placebo. Subsequently we performed the same analysis, 
but now with the Tyr-only group vs. AL-CR stimulation plus Tyr vs. CL-AR stimulation plus 
Tyr as between-subjects factor. This analysis did show a significant effect of group, F(1, 50) 
= 11.84, p > .001, partial η2 = .321. All three groups differed significantly from each other, 
with participants in the Tyr-only condition having significantly higher d’ prime scores than 
participants in the CL-AR stimulation plus Tyr condition, p = .018, and the AL-CR 
stimulation plus Tyr condition, p < .001, and with the CL-AR stimulation plus Tyr condition 
also showing higher scores than the AL-CR stimulation plus Tyr condition, p = .022.  
 
3.2.4 BMI. For the sake of clarity we discuss the BMI results in this separate section. There 
were significant main effects of BMI only when comparing d’ prime scores after CL-AR plus 
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placebo versus CL-AR plus Tyr, p = .034, and when comparing d’ prime scores for all three 
placebo conditions (AL-CR plus placebo, CL-AR plus placebo, and placebo-only), p = .032. 
In both analyses a higher BMI was associated with worse performance and we revisit this 
point in the discussion. Importantly, all other main effects of BMI were not significant nor did 
BMI interact significantly with load, all ps > .05. In separate analyses we confirmed BMI did 
not interact with tDCS montage and Tyr supplementation, indicating the effect of BMI was 
comparable in all groups, all ps > .05. 
 
4. Discussion 
The present study reports two major findings. First, we show Tyr administration, which 
presumably induces a modest increase in DA, enhances verbal WM performance as assessed 
in a letter-based N-back task. This finding replicates previous studies showing beneficial 
effects of Tyr on WM (for a review, see Jongkees et al., 2015). Second, we show that Tyr, and 
therewith presumably DA, modulates the effect of tDCS on verbal WM in a current direction-
dependent manner. Whereas previous studies show AL-CR stimulation of DLPFC benefits 
WM performance (Fregni et al., 2005; Hoy et al., 2013; Jeon & Han, 2012; Mulquiney et al., 
2011; Ohn et al., 2008; Oliveira et al., 2013; Teo et al., 2011) and CL-AR stimulation may 
impair performance (Marshall et al., 2005), in our study tDCS combined with Tyr led to a 
different pattern: CL-AR stimulation of the DLPFC led to higher WM performance than AL-
CR stimulation when both are combined with Tyr. This finding is in line with previous 
genetic studies showing higher prefrontal DA is associated with differential responses to 
tDCS over DLPFC (Nieratschker et al., 2015; Plewnia et al., 2013) and also fits the finding 
that combining a DA agonist with anodal stimulation of the motor cortex inverts tDCS after-
effects, leading to excitability diminishment rather than enhancement (M.-F. Kuo et al., 
2008). 
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These results provide first tentative evidence for a causal role of DA in modulating the 
cognitive-behavioral effect of tDCS over the prefrontal cortex. In doing so, this study supports 
the hypothesis that DA function may be one factor that contributes to variability in results of 
tDCS studies. This idea could have relevance for our null-finding in experiment 2: after 
placebo intake we found no difference in performance after AL-CR as compared to CL-AR 
stimulation, although the former typically enhances and the latter typically impairs WM. 
Many reasons may account for this null-finding. However, based on our finding that DA 
modulates the effects of tDCS, we speculate inter-individual variability in DA function might 
be one factor, either alone or in combination with others, that could explain this lack of 
difference. In order to prevent such difficult-to-interpret null-findings, we encourage future 
studies to take into account individual differences related to DA. Doing so would be an 
important step towards obtaining a clearer and consistent view of the efficacy of tDCS in 
modulating cognitive-behavioral performance.  
As mentioned in the introduction, it remains unclear what the precise mechanism is 
that underlies the interaction between DA and tDCS. It might be DA, and by extension Tyr, 
affects excitability modulations by online tDCS via an influence on membrane potentials, as 
DA can enhance neural firing in neurons with high potentials while suppressing firing in 
neurons with low potentials (Frank, 2005; Hernández-López et al., 1997). Hence DA and Tyr 
may affect online tDCS, i.e. stimulation during the critical task, by modulating task-induced 
activity, which has been identified as a determinant of tDCS effects (Antal et al., 2007; 
Bortoletto et al., 2015). DA and Tyr may also affect neuroplasticity induced by tDCS, which 
may have occurred in the present study, by affecting the NMDA-receptors that are believed to 
underlie the after-effects of tDCS (Liebetanz et al., 2002; Nitsche et al., 2004; Nitsche, Fricke, 
et al., 2003). Indeed, D1 and D2 receptors have been shown to affect NMDA-receptor-
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mediated LTP and LTD, although results for D2 receptors have been inconsistent (Gurden et 
al., 2000; Huang et al., 2004; Spencer & Murphy, 2000).  
Additionally, there are alternative but related hypotheses on the interaction between 
DA and tDCS and these are not necessarily mutually-exclusive. (i) Tanaka et al. (2013) 
showed cathodal tDCS increased DA in the rat striatum. As the relationship between DA and 
cognitive performance typically follows an inverted-U curve (Cools & D’Esposito, 2011), it 
has been argued tDCS might shift an individual’s DA level towards an optimum associated 
with peak performance (L. M. Li et al., 2015). Thus, response to tDCS would depend in part 
on an individual’s initial position relative to the optimal level of DA. This would be 
particularly relevant for the large body of tDCS studies in aging (Perceval, Flöel, & Meinzer, 
2016), as the interaction between DA and tDCS might be magnified by the interplay between 
genes, DA function, and aging (S.-C. Li, Lindenberger, & Bäckman, 2010; Lindenberger et 
al., 2008). (ii) One hypothesis, which might explain why cathodal tDCS of the left DLPFC in 
conjunction with Tyr led to higher WM scores than the same stimulation without Tyr, is the 
combination of high DA levels and cathodal stimulation may improve the signal-to-noise ratio 
in the brain (M.-F. Kuo et al., 2008), allowing for more efficient neural function. Future 
studies may be able to validate these speculations, for example by showing enhanced cortical 
efficiency as indicated by reduced BOLD response during task engagement. (iii) An 
alternative mechanism relates to the calcium-dependence of tDCS-induced excitability 
alterations, DA activity, and task-related cortical activity alterations, probably transmitted via 
the glutamatergic system. Hereby it is important to acknowledge the effect of calcium 
enhancement on long-lasting cortical excitability alterations follows a non-linear rule. Low 
calcium enhancement results in reduced, whereas high calcium results in enhanced activity 
and excitability, but even larger calcium enhancement again reduces respective activity and 
excitability, possibly due to counter-regulative activation of potassium channels (Lisman, 
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2001; Misonou et al., 2004). Accordingly, it was shown recently that enhancing stimulation 
duration of anodal tDCS or combination of anodal tDCS with nicotine in non-smokers results 
in reduced cortical excitability, and that this process is calcium dependent (Lugon et al., 2015; 
Monte-Silva et al., 2013). Likewise, enhancing stimulation intensity of cathodal tDCS 
switched the effects from excitability diminution to enhancement (Batsikadze, Moliadze, 
Paulus, Kuo, & Nitsche, 2013). One could speculate that in the present experiment task-
dependent activation of neurons in combination with Tyr and anodal tDCS over left DLPFC 
led to a calcium overflow resulting in cortical activity reduction, and thus reduced 
performance, whereas the slight calcium increase probably caused by cathodal tDCS over left 
DLPFC in conjunction with Tyr optimized task-relevant calcium enhancement, and thus 
improved performance. Notably, performance after CL-AR stimulation combined with Tyr 
was still lower than after Tyr intake without tDCS, suggesting the effects of tDCS and a DA 
manipulation might not be additive and their combination might not be an enhancing method 
for all individuals. (iv) Lastly and particularly relevant for online assessment of performance, 
the effect of tDCS seems to strongly depend on task-induced activity, at least in the motor 
cortex (Antal et al., 2007; Bortoletto et al., 2015). Hence the same stimulation might have 
different effects depending on the extent to which neural activity is increased during task 
performance. On the other hand, DA is known to modulate task-induced activity and, indeed, 
the functional polymorphism in the COMT gene, which affects prefrontal DA degradation, is 
associated with different levels of prefrontal activation during WM engagement (Egan et al., 
2001; Mattay et al., 2003). In line with this reasoning, the same COMT polymorphism 
modulates the effect of tDCS on executive function (Nieratschker et al., 2015; Plewnia et al., 
2013). Hence we speculate individual differences related to genetically predetermined DA 
levels might influence the extent of neural activation during WM engagement and, in turn, 
this variability could lead to different effects of online tDCS.  
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Related to the topic of individual differences, we recommend future research to 
employ more adaptive WM tasks instead of ‘static’ tasks with the same conditions for each 
participant. For example, instead of having each participant perform a 2 and 3-back task, 
adaptive versions of the N-back task exist wherein N increases when participants perform well 
on the task and N decreases when they perform worse (e.g. Jaeggi, Buschkuehl, Shah, & 
Jonides, 2014). Such tasks can prove useful in future research that wishes to examine 
individual differences (and gain) in WM performance, as it can prevent ceiling effects from 
obscuring individual differences and practice effects from confounding effects of 
experimental manipulations in within-subjects designs. Also, it is interesting to note some of 
our analyses revealed a tendency for WM to be worse with increasing BMI, which is 
consistent with the idea obesity is related to impaired cognitive function (Prickett, Brennan, & 
Stolwyk, 2015). With respect to this finding it is important to note our experimental groups 
did not differ in terms of BMI. Future research might wish to further investigate the potential 
relationship between BMI and WM without having the results confounded by administration 
of Tyr or tDCS. 
Future research may also wish to examine one notable difference between our and 
previous tDCS studies, which is that in the current experiment participants fasted overnight 
because of the Tyr administration. As of yet it is unclear if and how this might have affected 
the effects of tDCS and whether this fasting, perhaps in combination with Tyr and tDCS, may 
have contributed to the lack of an effect of tDCS on WM in the placebo conditions. Hence, it 
would be interesting for future studies to assess whether fasting can affect tDCS outcome. 
Furthermore, it is important to acknowledge DA is probably one of many 
neurotransmitters relevant to tDCS effects, and thus future research should explore other 
neurotransmitter systems as well. As reviewed by (Stagg & Nitsche, 2011), a number of 
neurotransmitters are known to modulate the physiological effects of tDCS, but these 
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investigations are restricted to the motor cortex and thus it remains unclear if and how these 
neurotransmitter determine cognitive-behavioral effects of tDCS. Important neurotransmitters 
that have been identified are glutamate and GABA, and their concentration levels change 
following anodal or cathodal stimulation over the motor cortex (Bachtiar, Near, Johansen-
Berg, & Stagg, 2015; Kim, Stephenson, Morris, & Jackson, 2014; Stagg et al., 2009). The 
consequent change in cortical excitation may facilitate or impair induction of LTP and LTD 
(Ziemann, Muellbacher, Hallett, & Cohen, 2001), and as such these neurotransmitters may 
play a crucial role in the neuroplastic after-effects of tDCS (Stagg & Nitsche, 2011). 
Interestingly, individuals are known to differ in the balance between cortical glutamate and 
GABA, and this balance has been shown to predict response selection (de la Vega et al., 
2014). Hence it would be interesting to see whether response to prefrontal tDCS can also be 
predicted based on individual differences in the glutamate/GABA balance. Other relevant 
neurotransmitters include acetylcholine, an increase of which abolished the after-effects 
anodal but prolonged the effects of cathodal tDCS (M.-F. Kuo, Grosch, Fregni, Paulus, & 
Nitsche, 2007), and serotonin, an increase of which prolonged the after-effects of anodal 
tDCS but reversed the after-effects of cathodal tDCS from excitability diminishment into 
enhancement (Nitsche, Kuo, Karrasch, et al., 2009). Recently it was also shown noradrenaline 
modulates tDCS-induced plasticity, with different effects for acute and chronic 
pharmacological enhancement of noradrenaline activity (H.-I. Kuo et al., 2016). This is 
particularly interesting when considering effects of Tyr administration may be mediated by 
DA and/or noradrenaline (Jongkees et al., 2015), as mentioned below. As such, future studies 
may wish to examine individual differences in terms of these neurotransmitters as well. 
Before concluding, we wish to elaborate on some limitations of this study. First, in 
experiment 2 we did not include a sham-tDCS condition. Hence we cannot be sure the 
observed effects of tDCS are due to modulation of neural physiology or rather due to 
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expectations of the participants evoked by the experience of mounting electrodes on the head 
and the accompanying tingling, burning sensations. However, we argue that an explanation of 
our results in terms of participants’ expectations is unlikely as the placebo groups from both 
experiments were comparable in performance. If participants’ expectations due to tDCS had 
indeed influenced our results, it would have likely resulted in differences between these 
groups. 
The second limitation is we did not assess inter-individual variability in DA function, 
for example in terms of genetic polymorphisms. Although the present study aimed at finding 
proof-of-principle for the idea DA modulates prefrontal tDCS, not considering individual 
differences between our participants may have led to the inability to replicate a beneficial 
effect of tDCS on WM. For this reason it would be valuable to replicate and validate our 
findings in future studies in which individual differences are taken into account. 
The third limitation relates to the presumed effect of Tyr on catecholamine synthesis. 
Tyr is the precursor of both DA and noradrenaline (NA) and beneficial effects of Tyr on 
cognition may be mediated by increases in either DA or NA, or both (Jongkees et al., 2015). 
For this reason we cannot definitively conclude that the findings reported in the present study 
are mediated solely by DA and not by NA, in particular as pharmacological enhancement of 
NA has recently been shown to modulate tDCS-induced plasticity (H.-I. Kuo et al., 2016). 
There is evidence that in particular DA modulates the effect of tDCS, as DA antagonists can 
abolish the effect of tDCS on cortical excitability (Nitsche et al., 2006), but more research is 
necessary before we could conclude the effects of Tyr on tDCS are mediated solely by DA.  
Lastly, it is important to consider that our results may have depended significantly on 
our choice of stimulation parameters, such as location of the return electrode, size of the 
electrodes, applying stimulation before or during the task of interest, the current intensity, and 
stimulation duration. tDCS studies so far have used many different parameters, which may 
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play an under-investigated role in determining the efficacy of the stimulation (see Woods et 
al., 2016). This highlights the possibility our results could have been different had we chosen 
different parameters, and future research should aim to systematically investigate whether the 
influence of DA on tDCS might depend on these parameters to produce different cognitive-
behavioral outcomes.  
Although more research is needed, the present study provides first evidence that Tyr 
administration modulates the cognitive-behavioral effects of tDCS and, in doing so, 
tentatively supports the hypothesis that DA plays a causal role in prefrontal tDCS. Despite 
probably being only one of many important factors, we recommend future studies to consider 
the effects of DA on tDCS in order to achieve more consistent and replicable results.  
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Table 1. Group demographics for Experiment 1 and 2. 
 Experiment 1    Experiment 2        
     AL-CR    CL-AR    
 Placebo  Tyrosine  Placebo  Tyrosine  Placebo  Tyrosine  
 Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD 
Age (years) 20.8 1.9 22.2 2.4 20.8 2.0 19.7 1.7 20.7 2.3 20.9 1.4 
Weight (kg) 62.7 7.6 64.1 4.7 63.2 6.1 62.5 8.1 65.8 9.3 68.5 9.7 
BMI (kg/length
2
) 21.6 2.3 22.0 2.1 22.3 2.5 21.5 2.1 22.6 2.3 22.7 2.4 
Female/male 
ratio 
17/1  17/1  15/3  16/2  15/3  15/3  
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Table 2. Parameters of the N-back task in Experiment 1 
 Placebo  Tyrosine  
 Mean SD Mean SD 
Hits*     
2-back .83 .15 .91 .07 
3-back .72 .15 .82 .12 
Misses*     
2-back .17 .15 .09 .07 
3-back .28 .15 .18 .12 
Correct rejections*     
2-back .88 .12 .93 .05 
3-back
 
.81 .11 .90 .06 
False alarms*     
2-back .12 .12 .07 .05 
3-back
 
.19 .11 .10 .06 
Reaction times 2-back     
Target 541 83 506 71 
Non-target* 568 90 528 65 
Reaction times 3 back     
Target 606 86 544 68 
Non-target* 608 78 579 60 
* p < .05     
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Table 3. Parameters of the N-back task in Experiment 2 
 tDCS montage 
 AL-CR    CL-AR    
 Placebo  Tyrosine  Placebo  Tyrosine  
 Mean SD Mean SD Mean SD Mean SD 
Hits*         
2-back .84 .08 .80 .10 .83 .11 .87 .08 
3-back .75 .11 .71 .10 .71 .13 .76 .11 
Misses*         
2-back .16 .08 .20 .10 .17 .11 .13 .08 
3-back .25 .11 .29 .10 .29 .13 .24 .11 
Correct rejections         
2-back .89 .06 .89 .06 .88 .07 .89 .05 
3-back
o 
.83 .07 .79 .07 .85 .06 .85 .09 
False alarms         
2-back .11 .06 .11 .06 .12 .07 .11 .05 
3-back
o 
.17 .07 .21 .07 .15 .06 .15 .09 
Reaction times 2-
back 
        
Target 534 55 542 80 539 81 560 87 
Non-target 602 61 578 62 581 69 595 71 
Reaction times 3 
back 
        
Target 555 67 566 64 562 67 567 84 
Non-target 607 69 592 41 602 74 609 67 
* p < .05 for difference AL-CR plus Tyr versus CL-AR plus Tyr 
o
 p < .05 for difference AL-CR versus CL-AR, regardless of Tyr administration 
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Figure 1. Mean d' prime scores in the N-back task for each group in experiment 1 (no stimulation plus placebo or Tyr) and experiment 2 (CL-AR 
stimulation plus placebo or Tyr and AL-CR stimulation plus placebo or Tyr). Scores are averaged across the two WM load conditions (2-back 
and 3-back). * p < .05 
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